Skip to content

Study on the applied dose of nalbuphine in hysteroscopy of different patients

Study on the relationship between the effective dose of naborphine combined with propofol in hysteroscopy and age and fertility

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068515
Enrollment
Unknown
Registered
2023-02-22
Start date
2023-02-22
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative analgesia and sedation

Interventions

Young and middle-aged childless group:Different doses of Nalbuphine
Young and middle-aged childbearing group:Different doses of Nalbuphine
Elderly group:Different doses of Nalbuphin

Sponsors

Shaanxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Age: 18-85; ?BMI18.5-27.9 ? ASA classification: Class I - II; ? Patients who are scheduled to undergo hysteroscopy; ? Volunteered to participate in this study, and was informed in detail and signed the informed consent form

Exclusion criteria

Exclusion criteria: ? Patients with severe anemia; ? Patients with severe hypertension (systolic blood pressure>180mmHg, and/or diastolic blood pressure>110mmHg); Patients with pulmonary infection and asthma history; ? Patients with neurological and psychiatric diseases; ? Patients with hyperthyroidism and hypothyroidism; ? Those who cannot communicate or cooperate; ? Allergic or addicted to the drugs related to the study; ? Complicated with severe heart, lung, liver and kidney diseases.

Design outcomes

Primary

MeasureTime frame
Intraoperative limb activity rate;Incidence of respiratory depression;Incidence of adverse reactions such as dizziness, nausea and vomiting after operation;Incidence of postoperative abdominal pain;

Secondary

MeasureTime frame
heart rate;blood pressure;Blood oxygen saturation;eyelash reflex disappears;Postoperative recovery time;Operation completion time;Total dosage of propofol;Analgesic effect (measured by NRS scale);Sedative effect (measured by Ramsay scale);Postoperative recovery of consciousness and movement (measured by 4CRT test);

Countries

China

Contacts

Public ContactCao Yuan

Shaanxi Provincial People's Hospital

563416085@qq.com13119182729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026